David Colleran - Mar 9, 2023 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
EVP, General Counsel, Corp Sec
Signature
/s/ David Colleran
Stock symbol
ANIK
Transactions as of
Mar 9, 2023
Transactions value $
-$29,090
Form type
4
Date filed
3/10/2023, 03:51 PM
Previous filing
Mar 7, 2023
Next filing
Mar 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Options Exercise $0 +3.68K +30.01% $0.00 16K Mar 9, 2023 Direct F1
transaction ANIK Common Stock Tax liability -$29.1K -1.08K -6.77% $26.91 14.9K Mar 9, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIK Restricted Stock Unit Award $0 +16.4K $0.00 16.4K Mar 9, 2023 Common Stock 16.4K $0.00 Direct F4
transaction ANIK Stock Option (Right to Buy) Award $0 +35.8K $0.00 35.8K Mar 9, 2023 Common Stock 35.8K $29.60 Direct F5, F6
transaction ANIK Restricted Stock Unit Options Exercise $0 -3.68K -50.01% $0.00 3.68K Mar 9, 2023 Common Stock 3.68K $0.00 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.
F2 Reflects an aggregate of 1,081 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2023.
F3 Reflects the closing price of ANIK common stock on March 9, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
F4 Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
F5 Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
F6 The premium priced stock options vest in three equal annual installments beginning on March 9, 2024.
F7 Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.